NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹2,180 Cr | ₹1,833 Cr | ₹1,580 Cr | ₹1,383 Cr | ₹1,325 Cr |
What is the latest Total Liabilities ratio of NEULAND LABORATORIES ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹2,180 Cr |
Mar2024 | ₹1,833 Cr |
Mar2023 | ₹1,580 Cr |
Mar2022 | ₹1,383 Cr |
Mar2021 | ₹1,325 Cr |
How is Total Liabilities of NEULAND LABORATORIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹2,180 Cr | 18.95 | |
Mar2024 | ₹1,833 Cr | 16.00 | |
Mar2023 | ₹1,580 Cr | 14.19 | |
Mar2022 | ₹1,383 Cr | 4.43 | |
Mar2021 | ₹1,325 Cr | - |
Compare Total Liabilities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹17,529.9 Cr | -5.5% | 11.8% | 74.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,712.0 Cr | -1.2% | 1.3% | 5.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,623.0 Cr | -2% | 1.3% | 45.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,285.0 Cr | 1.4% | 11.9% | 15.7% | Stock Analytics | |
CIPLA | ₹119,010.0 Cr | -0.6% | -2% | -1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,118.0 Cr | -1.2% | -6.7% | -8.4% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -5.5% |
11.8% |
74.4% |
SENSEX | 0.1% |
1% |
2.6% |
You may also like the below Video Courses